1. Approves the incremental funding recommended for each country disease component, and its constituent grants, as listed in Tables 1A and 1B of Section IV to GF/B36/ER01 ("Table 1A" and "Table 1B");
2. Acknowledges each country disease component's constituent grants will be implemented by the proposed Principal Recipients listed in Tables 1A and 1B, or any other Principal Recipient(s) deemed appropriate by the Secretariat in accordance with Global Fund policies;
3. Affirms the incremental funding approved under this decision (a) increases the upper-ceiling amount that may be available for the relevant implementation period of each country disease component's constituent grants, (b) is subject to the availability of funding, and (c) shall be committed in annual tranches; and
4. Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country disease component among its constituent grants, provided that the Technical Review Panel (the "TRP") validates any redistribution that constitutes a material change from the program and funding request initially reviewed and recommended by the TRP.
This decision does not have material budgetary implications for the 2016 Operating Expenses Budget.
See attached table detailing total recommended funding amount for the following grants: SLV-HMOH, SLV-HPLAN, GYA-MMOH, QSE-HAFAO. More on Funding Decisions.